- Home
- IRWD vs RXST Comparison
IRWD vs RXST Comparison
Compare IRWD & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRWD | RXST |
|---|---|---|
| Founded | 1998 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.6M | 524.6M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IRWD | RXST |
|---|---|---|
| Price | $3.32 | $10.58 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 11 |
| Target Price | $5.34 | ★ $11.30 |
| AVG Volume (30 Days) | ★ 2.3M | 769.7K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $338,987,000.00 | $142,085,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.01 | $4.26 |
| P/E Ratio | $19.03 | ★ N/A |
| Revenue Growth | N/A | ★ 10.75 |
| 52 Week Low | $0.53 | $6.32 |
| 52 Week High | $4.78 | $37.13 |
Technical Indicators
Market Signals| Indicator | IRWD | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 41.07 |
| Support Level | $3.11 | $10.50 |
| Resistance Level | $3.39 | $13.14 |
| Average True Range (ATR) | 0.20 | 0.61 |
| MACD | -0.06 | -0.32 |
| Stochastic Oscillator | 36.36 | 4.89 |
Price Performance
Historical ComparisonAbout IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.